Skip to Content

Linagliptin

In the US, Linagliptin (linagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BH05

CAS registry number (Chemical Abstracts Service)

0668270-12-0

Chemical Formula

C25-H28-N8-O2

Molecular Weight

472

Therapeutic Category

Oral antidiabetic agent: Dipeptidyl peptidase-4 (DPP-4) inhibitor, gliptin

Chemical Names

1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butn-1-yl)-3,7-dihydro-3-metyl-1-[(4-metyl-2-quinazolinyl)metyl]-

8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-metyl-1-[(4-metylquinazolin-2-yl)metyl]-3,7-dihydro-1H-purine-2,6-dione (WHO, USAN, JAN)

Foreign Names

  • Linagliptinum (Latin)
  • Linagliptin (German)
  • Linagliptine (French)
  • Linagliptina (Spanish)

Generic Names

  • Linagliptin (OS: USAN, JAN, BAN)
  • BI-1356 (IS)
  • BS 1356 (IS)
  • UNII-3X29ZEJ4R2 (IS)

Brand Names

  • Glyxambi (Linagliptin and Empagliflozin)
    Boehringer Ingelheim Pharmaceuticals, United States
  • Jentadueto (Linagliptin and Metformin)
    Boehringer Ingelheim, Bosnia & Herzegowina; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Canada; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Finland; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Lithuania; Boehringer Ingelheim, Latvia; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim España, Spain; Boehringer Ingelheim International, Austria; Boehringer Ingelheim Pharmaceuticals, United States
  • Tradjenta
    Boehringer Ingelheim Pharmaceuticals, United States
  • Trajenta
    Boehringer Ingelheim, Australia; Boehringer Ingelheim, Bosnia & Herzegowina; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Canada; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, China; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Finland; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Israel; Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Lebanon; Boehringer Ingelheim, Lithuania; Boehringer Ingelheim, Latvia; Boehringer Ingelheim, Malaysia; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Philippines; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Vietnam; Boehringer Ingelheim España, Spain; Boehringer Ingelheim International, Austria; Boehringer Ingelheim International, Russian Federation; Boehringer Ingelheim Singapore, Singapore
  • Trajenta - Duo (Linagliptin and Metformin)
    Boehringer Ingelheim, Israel
  • Trajenta Duo (Linagliptin and Metformin)
    Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, South Korea; Boehringer Ingelheim, Malaysia; Boehringer Ingelheim Singapore, Singapore
  • Trayenta
    Boeh.Ingel., Argentina; Boehringer Ingelheim, Chile; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Panama; Boehringer Ingelheim, El Salvador
  • Trayenta Duo (Linagliptin and Metformin)
    Boehringer Ingelheim, Chile; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Mexico
  • Trazenta
    Nippon Boehringer Ingelheim, Japan

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide